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Valorisation is “the process of creating value from knowledge, by making this 
knowledge available and suitable for economic and social exploitation and to translate 
this knowledge into products, services, processes and new business.” 
This chapter will discuss the current findings in the light of the impact as well as innova-
tive concepts for future health care. 
RELEVANCE 
COPD is a highly prevalent chronic disease, which is projected to further increase in the 
coming decades. Worldwide COPD is a leading cause of morbidity and mortality, result-
ing in a substantial and increasing economic and social burden. While COPD is character-
ized by airflow limitation, the degree of airflow limitation poorly correlates with actual 
disease burden. In fact, the COPD patient’s health status is largely determined by extra-
pulmonary manifestations and comorbidities including skeletal muscle dysfunction, oste-
oporosis, cardiovascular disease, metabolic syndrome, and psychological disorders. 
These comorbidities contribute to common symptoms (breathlessness, fatigue), but also 
to reduced physical activity, disease exacerbations, hospital admissions and mortality.  
This thesis highlights the importance of skeletal muscle dysfunction and in particular, 
low muscle mass as screening and therapeutic target for COPD: 
Sarcopenia is defined as low appendicular muscle mass together with low muscle func-
tion (strength or performance) by the European Working Group on Sarcopenia. Recent-
ly, sarcopenia has been recognized as a disease entity with an ICD-10-CM (M62.84) 
code. Our findings indicate that assessment of 3-compartimental body composition 
(appendicular muscle mass, abdominal obesity and bone mineral content) might be 
favourable over 2-compartimental distinction between fat and fat-free mass, indicated 
by 1) the high persisting prevalence’s of sarcopenia and abdominal obesity in all BMI 
categories; 2) it’s discrimination for impaired muscle strength and endurance; 3) the 
higher predictive value of the 3-compartment prediction model compared to the 1 
(BMI) or 2-compartment models. Dual Energy X-ray absorptiometry (DEXA) scans were 
originally designed for measurement of bone mineral density. This assessment is very 
relevant In COPD because of the high prevalence of osteoporosis in these patients 
(Chapter 2). Nowadays most hospitals are also able to use a DEXA scan for measure-
ment of body composition according to the 3-compartmentmodel.  
Next to low muscle mass, COPD patients often show structural alterations in muscle 
fiber type composition. Previous studies have already demonstrated a muscle fiber type 
III shift, and selective atrophy of the type IIx fibers in patients with COPD resulting in a 
loss of muscle oxidative phenotype. In an outpatient COPD population we revealed an 
even more pronounced decrease in type I muscle fibers in patients with sarcopenia, 
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compared with non-sarcopenic patients and healthy controls. Moreover, sarcopenic 
patients were characterized by selective atrophy of the type I fibers, independent of the 
more generalized type II atrophy in COPD as a whole. These findings could reflect a 
cross-talk between muscle mass and oxidative phenotype regulation, which might ac-
celerate the muscle wasting process in COPD. Future research in this presumed cross-
talk may provide new leads for targeted intervention. This study also indicates that 
sarcopenic patients with COPD seem extra vulnerable as not only their muscle mass but 
also muscle metabolism is affected.  
The cause of abnormalities in body composition and structural changes within muscle in 
COPD not only involve disease specific factors (e.g. hypoxia, systemic inflammation, 
oxidative stress and use of corticosteroids) but also lifestyle factors. Lifestyle factors 
mainly concern smoking and physical activity, but also dietary behaviour. A poor dietary 
quality may accelerate disturbances in body composition in COPD, but only limited 
studies have investigated dietary intake from this perspective. We demonstrated differ-
ences in the quality of dietary intake between COPD patients with different body com-
position profiles. Patients with a low muscle mass had a low dietary quality reflected by 
low intake of micronutrients, especially vitamin D, and a lower intake of protein. Pa-
tients with both low muscle mass and abdominal obesity appeared most susceptible for 
a poor dietary quality. Therefore more attention and guidance is required for COPD 
patients in order to respect recommendations regarding healthy nutrition. This is pres-
ently undervalued relative to modifying sedentary behaviour and smoking cessation. 
Exercise training is known to be effective in improving muscle function as well as exer-
cise tolerance in patients with advanced COPD and is considered to be the cornerstone 
of pulmonary rehabilitation. The COPD guidelines recommend nutritional supplementa-
tion to prevent weight loss and promote weight gain in undernourished patients with 
COPD. However, the potential of nutritional strategies to enhance the efficacy of exer-
cise training in COPD is not yet well established. The randomised placebo-controlled 
NUTRAIN-trial that we performed, investigated the additional effects of nutritional sup-
plementation on top of exercise training in patients with low muscle mass, as integral 
part of an out-patient pulmonary rehabilitation program. The nutritional intervention 
was therefore easily implementable.  
The results confirmed a good response to exercise training in COPD patients character-
ized by moderate airflow imitation and low muscle mass. New insights provided by this 
thesis include that, while targeted nutritional supplementation did not enhance muscle 
regain and improvements in lower limb muscle performance in these patients, benefi-
cial effects were observed on nutritional status and inspiratory muscle strength. An 
unexpected finding was the decline in daily physical activity after exercise training in the 
control group, which was prevented by nutritional supplementation. These results of 
the NUTRAIN-trial provide new leads for optimisation of medical nutrition. Furthermore 
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the trial highlights the necessity in nutritional therapy to distinguish between supple-
mentation of calories and protein and supplementation of specific nutrients. Moreover, 
the observed dissociation between physical performance and daily physical activity 
provides new leads for improvement of daily physical activity. 
HEALTH CARE PROVIDERS 
The present thesis gives important insights for health care providers. In order to develop 
and evaluate effective treatment strategies, individual assessment is required. Body com-
position needs to be assessed to distinguish not only muscle mass, but also to take body 
compositional shifts into account. These shifts include both the mass and distribution of 
muscle, fat and bone mineral density, which are able to serve as a stronger predictor of 
physical impairment. DEXA is the most appropriate tool for measurement of body compo-
sition, as it simultaneously allows for screening of highly prevalent osteoporosis in COPD. 
Assessment of dietary intake by dieticians is required not only to estimate total intake of 
calories, but also to identify possible nutrient deficiencies by comparing these with daily 
recommended intakes by the national Health Council. Daily intake of macro- and micronu-
trients is often below recommendations in COPD patients. An inadequate dietary intake 
might accelerate body compositional shifts, as reflected by differences in quality of dietary 
intake between patients with different body composition profiles. 
This thesis therefore underlines the need to further tailor and accentuate nutritional 
guidelines for specific metabolic phenotypes. Moreover, nutritional and pharmaceutical 
industries are challenged to develop and optimize medical nutrition and supplements 
for patients with COPD distinguishing in providing high energy and/or protein or specific 
nutrients (e.g. vitamin D, poly-unsaturated fatty acids, resveratrol, and nitrate).  
SCIENCE: FUTURE RESEARCH QUESTIONS 
The findings in the current thesis might be important for researchers in the field. 
Meanwhile several new questions were revealed, which are presented in the discussion 
chapter. Nonetheless the presented findings create new opportunities. Future studies 
are needed to investigate the efficacy of tailored nutritional interventions for carefully 
selected COPD patient subgroups defined according to distinct clinical phenotypes. 
Furthermore, the challenge for future studies is to disentangle the mechanism behind 
the observed dissociation between physical performance and daily physical activity 
resulting from nutritional supplementation. Identification and measurement of out-
come measures beyond muscle are required to unravel a broader potential of nutri-
tional modulation in COPD.   
